Skip to main content
. 2010 Jun 23;5(6):e11270. doi: 10.1371/journal.pone.0011270

Figure 1. Schematic of the Experimental Design with Constituent Experimental and Control Groups.

Figure 1

For all groups (except sham pMCAO controls that never undergo MCA occlusion) the red vertical line indicates time of permanent occlusion of the MCA (pMCAO), the x-axis at bottom demarcates the chronology of events post-occlusion, and the black dotted line indicates the initiation of all second day experimentation. (Note, however, that the behavior animals are examined for the first time at one week post-pMCAO). (A–L) Experimental paradigms and chronology of events are listed for animals undergoing either functional imaging or electrophysiology (M–O). Chronology of events for animals undergoing behavioral assessment one week post-occlusion (P-R). Experimental paradigms and chronology of events are listed for animals undergoing blood flow imaging. N-sizes for each treatment condition are as follows: (A) n = 7; (B) n = 3; (C) n = 7; (D) n = 8; (E) n = 7; (F) n = 5; (G) n = 2; (H) n = 3; (I) n = 3; (J) n = 3; (K) n = 3;(L) n = 21 (M) n = 22; (N) n = 22; (O) n = 22; (P) n = 13; (Q) n = 6;(R) n = 6.